Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydroamination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iridium catalyst enables anti-Markovnikov hydroamination. Enhances yield and stability for pharmaceutical intermediate manufacturing supply chains.
Discover high-purity indole-dihydronaphthalene intermediates via novel Rh/Pd dual catalysis. Enhanced enantioselectivity and cost-effective manufacturing for pharma.
Novel nickel imine complex catalyzes cyclohexylacetylene hydroamination. High yield, mild conditions, cost-effective manufacturing solution.
Patent CN110734378B reveals a mild Ni-catalyzed method for high-ee chiral allylamines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN115160146B reveals a high-yield one-pot synthesis for 1,2-cyclohexanediamine from cyclohexene oxide, offering significant cost reduction and supply chain stability for global buyers.
Patent CN101585788A reveals mild gold-catalyzed route for allyl sulfonamides, offering high purity and scalable cinnamaldehyde precursor synthesis.
Novel Rh-free synthesis of Sitagliptin phosphate ensuring high purity and cost efficiency for pharmaceutical supply chains.
Patent CN101314581B details a gold-catalyzed synthesis of N-sulfonyl ketimines offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN112479968A reveals a room-temperature hydroamination route using KI/KHSO4, offering a cost-effective alternative to transition metals for pharmaceutical intermediates.
Patent CN104262249A reveals solvent-free hydroamination for quinolones. Reduces waste and improves supply chain reliability for pharmaceutical manufacturers.
Novel copper-catalyzed hydroamination method offers high atom economy and mild conditions for scalable pharmaceutical intermediate production.
Novel aluminum catalyst enables anti-Markovnikov hydroamination with high yield. Reduces cost and improves supply chain reliability for amine synthesis.
Discover the atom-economical synthesis of 1,5-benzodiazepine derivatives using gold catalysis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Novel anti-Markovnikov hydroamination method using rare earth catalysts offers high purity pharmaceutical intermediates with reduced environmental impact and simplified supply chains.
Patent CN112521289B enables copper-catalyzed synthesis with mild conditions and high atom economy for reliable pharmaceutical intermediate supply chains.